[1] |
WANG Jiangtao, DU Yu, ZHU Ling, ZHAO Fouxi, HU Yuandong, LIU Tao.
Correlation between Lipid Accumulation Product and the Incidence of Hypertension in Adults: a Prospective Cohort Study
[J]. Chinese General Practice, 2025, 28(12): 1433-1438.
|
[2] |
SHI Jian, WANG Yajing, HOU Ran, HUANG Yajie, DUAN Xiaoyang.
Efficacy and Safety of EGFR-TKI Combined with Chemotherapy for the First-line Treatment of EGFR-mutated Advanced Non-small Cell Lung Cancer: a Meta-analysis
[J]. Chinese General Practice, 2025, 28(11): 1383-1394.
|
[3] |
GU Mingyu, QIN Tingting, QIAO Kun, BAI Xinyuan, WANG Yao, YANG Yutong, LI Xingming.
A Network Meta-analysis of Primary Hypertension Management Patterns in China
[J]. Chinese General Practice, 2025, 28(10): 1265-1272.
|
[4] |
SUN Lin, SHI Yiwei, HOU Xiaomin, GUO Yunting, ZHAO Xu, DONG Lin, NIE Jisheng, QIN Xiaojiang.
Relationship between Serum Sodium Levels and Length of Hospital Stay in Patients with Pulmonary Hypertension associated with Left Heart Disease
[J]. Chinese General Practice, 2025, 28(09): 1065-1071.
|
[5] |
ZHANG Minrui, LI Dan, HE Meihui, GAO Ruixiang.
Do Higher Intellectuals Trust Traditional Chinese Medicine More?
[J]. Chinese General Practice, 2025, 28(09): 1044-1051.
|
[6] |
WANG Yiquan, CHEN Wanjia, LIU Wangyi, ZHANG Luyun, DENG Yueyi.
The Prognosis of Stage 4 Chronic Kidney Diseasetreated with Fermented Cordyceps Sinensis Powder: Based on a Retrospective Cohort Study
[J]. Chinese General Practice, 2025, 28(09): 1084-1091.
|
[7] |
Expert Group on the Consensus for Blood Purification Therapy Based on Pharmacokinetics in Acute Poisoning from Commonly Used Clinical Drugs.
Consensus for Blood Purification Therapy Based on Pharmacokinetics in Acute Poisoning from Commonly Used Clinical Drugs
[J]. Chinese General Practice, 2025, 28(09): 1033-1043.
|
[8] |
Gynecological Oncology Group of the Oncology Department of Capital Medical University.
Expert Consensus on Management of Common Gynecological Malignancies Combining General Practice and Specialist
[J]. Chinese General Practice, 2025, 28(08): 911-922.
|
[9] |
SONG Fenfen, LI Shengmian.
Real-World Study of Camrelizumab-based Regimen for Locally Advanced and Metastatic Esophageal Cancer
[J]. Chinese General Practice, 2025, 28(07): 844-852.
|
[10] |
Diabetes Prevention and Control Committee of Chinese Preventive Medicine Association.
Chinese Diabetes Behavior and Lifestyle Intervention Guidelines (2024)
[J]. Chinese General Practice, 2025, 28(07): 777-796.
|
[11] |
FANG Xiang, SONG Haiqi, LIAO Xiaoyang, LIU Lidi, ZHANG Peng, JIA Yu, YANG Ziyu, YANG Rong, LIU Ruhui.
Recommendations for the Management of Hypertensive Disorders of Pregnancy in China: Based on the A Summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand Hypertension in Pregnancy Guideline
[J]. Chinese General Practice, 2025, 28(06): 649-654.
|
[12] |
ZHANG Wenjie, LI Jun, CHEN Hengwen, TAN Yuqing, XIE Zicong, WU Ji, MENG Chao, LI Zhaoling, ZHANG Lesong.
Collection and Determination of Clinical Problems and Outcome Indicators of Expert Consensus on Clinical Application of Ethnic Medicine in the Treatment of Palpitation (Arrhythmia-premature Ventricular Complexes)
[J]. Chinese General Practice, 2025, 28(04): 407-412.
|
[13] |
Phillips William R., Sturgiss Elizabeth, Glasziou Paul, olde Hartman Tim C., Orkin Aaron M., Prathivadi Pallavi, Reeve Joanne, Russell Grant M., van Weel Chris.
Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care—the CRISP Statement
[J]. Chinese General Practice, 2025, 28(04): 385-392.
|
[14] |
YANG Hui, WANG Yang, CHEN Qingqi, LIU Chenxi, GU Jie, ZHAO Yang, QIN Jiangmei, CAO Xinyang, Sturgiss Elizabeth, Phillips William R., XU Yanli.
Applying the Consensus Reporting Items for Studies in Primary Care Checklist to Improve Reporting Quality in Primary Care Research in China
[J]. Chinese General Practice, 2025, 28(04): 393-401.
|
[15] |
LI Hongmei, ZHANG Yimin, WANG Yong, ZHANG Yurong, JIA Xiao, YU Jingjing, SANG Die.
Aerobic Exercise Improves Physique and Quality of Life in Breast Cancer Patients During Anthracycline-based Chemotherapy: a Randomized Controlled Trial
[J]. Chinese General Practice, 2025, 28(03): 285-292.
|